Published in Cancer Weekly, November 29th, 2011
The BBVA Foundation Tumor Biomarkers Research Program will provide 2.5 million euros over the next five years to fund the collaborative efforts of MGH and VHIO. MGH has also committed to match up to 1.25 million euros of the BBVA Foundation contribution. Funding for the research may be increased according to economic circumstances and as need arises.
"We are grateful that the BBVA Foundation is not only...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.